Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.51 USD | -1.15% | +3.42% | -15.30% |
Financials (USD)
Sales 2024 * | 632M | Sales 2025 * | 708M | Capitalization | 2.87B |
---|---|---|---|---|---|
Net income 2024 * | 109M | Net income 2025 * | 148M | EV / Sales 2024 * | 3.49 x |
Net cash position 2024 * | 659M | Net cash position 2025 * | 748M | EV / Sales 2025 * | 2.99 x |
P/E ratio 2024 * |
28.6
x | P/E ratio 2025 * |
21.4
x | Employees | 352 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.18% |
Latest transcript on Corcept Therapeutics Incorporated
1 day | -1.15% | ||
1 week | +3.42% | ||
Current month | +17.97% | ||
1 month | +17.61% | ||
3 months | +21.14% | ||
6 months | +9.56% | ||
Current year | -15.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Atabak Mokari
DFI | Director of Finance/CFO | 47 | 21-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Belanoff
FOU | Founder | 66 | 98-05-12 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-03-11 |
George Baker
BRD | Director/Board Member | 81 | 98-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.71% | 28 M€ | -0.39% | ||
0.30% | 43 M€ | +4.31% | ||
0.27% | 25 M€ | -1.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 27.54 | -1.04% | 729,938 |
24-05-15 | 27.83 | +0.61% | 682,542 |
24-05-14 | 27.66 | +0.47% | 1,090,879 |
24-05-13 | 27.53 | +1.81% | 1,769,182 |
24-05-10 | 27.04 | +1.65% | 1,547,905 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.30% | 2.9B | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- CORT Stock